Boehringer Ingelheim Singapore Pte Ltd

Boehringer Ingelheim Singapore Pte Ltd is the Singapore arm of the German family-owned pharmaceutical company. Boehringer Ingelheim Singapore Pte Ltd manages commercial operations for respiratory medicines including Spiriva and Ofev, diabetes treatment Jardiance, cardiology and oncology medicines for Singapore’s healthcare market. The company’s research in COPD, diabetes, heart failure, and fibrotic diseases serves Singapore’s chronic disease burden with innovative pharmaceutical solutions back.